For each citation that was shared on social media (LinkedIn, Facebook, or Twitter) with the “@GenScript” tag, the author will be rewarded with a $10 Amazon gift card or 2,000 GS points.

Metasurface-Driven and Nanomaterial-Coupled Plasmonic Biosensor for the Rapid and Quantitative Clinical Identification of Neutralizing Antibodies against SARS-CoV-2 Variants

Advanced Functional Materials. 2023-09; 
Rui Li, Ya Zhao, Hongli Fan, Hanlin Zhou, Shaoping Yin, Qiang Zhang, Meilin Jin,Gang L. Liu,and Liping Huang
Products/Services Used Details Operation
Gene Synthesis The pCMV-mFc expression vector was purchased from Genscript Biotech Corporation Co., Ltd (Nanjing, China) Get A Quote


A robust serological test is required to detect neutralizing antibodies (NAbs) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A nanomaterial-coupled metasurface plasmon resonance (MetaSPR) biosensor is developed for rapid multiplexing quantitative tests of the half maximal inhibitory concentration (IC50) value of SARS-CoV-2 NAbs in human sera. This biosensor is applied to a MetaSPR competitive or surrogate virus neutralization test (MSPR VNT) used for quantifying NAb-mediated blockage of the interaction between the human angiotensin-converting enzyme 2 (hACE2) receptor and the receptor-binding domain (RBD) of the SARS-CoV-2 spike protein. Novel nanomaterial, gold platinum nanoflowers (A... More